Hemo Organic Ltd
₹ 12.5
6.84%
23 May
3:12 p.m.
About
Incorporated in 1992, Hemo Organic Ltd manufactures Ayurvedik or Unani pharmaceutical preparation[1]
Key Points
- Market Cap ₹ 4.34 Cr.
- Current Price ₹ 12.5
- High / Low ₹ 15.2 / 8.05
- Stock P/E 27.1
- Book Value ₹ -0.43
- Dividend Yield 0.00 %
- ROCE 2.65 %
- ROE %
- Face Value ₹ 10.0
Pros
Cons
- Promoter holding is low: 16.8%
- Company has high debtors of 382 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0.71 | 0.16 | 0.11 | 0.60 | 0.09 | 0.05 | 0.27 | 0.01 | 0.01 | 0.00 | 0.01 | 2.41 | |
0.79 | 0.22 | 0.16 | 0.68 | 0.24 | 0.17 | 0.29 | 0.06 | 0.07 | 0.05 | 0.25 | 2.45 | |
Operating Profit | -0.08 | -0.06 | -0.05 | -0.08 | -0.15 | -0.12 | -0.02 | -0.05 | -0.06 | -0.05 | -0.24 | -0.04 |
OPM % | -11.27% | -37.50% | -45.45% | -13.33% | -166.67% | -240.00% | -7.41% | -500.00% | -600.00% | -2,400.00% | -1.66% | |
0.23 | 0.02 | -0.71 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.07 | |
Interest | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 |
Depreciation | 0.09 | 0.07 | 0.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit before tax | 0.04 | -0.11 | -0.82 | -0.08 | -0.15 | -0.12 | -0.02 | -0.05 | -0.06 | -0.05 | -0.26 | 0.03 |
Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -466.67% |
0.04 | -0.11 | -0.82 | -0.08 | -0.15 | -0.12 | -0.02 | -0.05 | -0.06 | -0.05 | -0.26 | 0.16 | |
EPS in Rs | 0.12 | -0.32 | -2.37 | -0.23 | -0.43 | -0.35 | -0.06 | -0.14 | -0.17 | -0.14 | -0.75 | 0.46 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 31% |
5 Years: | 55% |
3 Years: | 522% |
TTM: | 24000% |
Compounded Profit Growth | |
---|---|
10 Years: | 13% |
5 Years: | 58% |
3 Years: | 67% |
TTM: | 162% |
Stock Price CAGR | |
---|---|
10 Years: | -2% |
5 Years: | 0% |
3 Years: | -37% |
1 Year: | 3% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | % |
Balance Sheet
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 3.40 | 3.40 | 3.40 | 3.47 | 3.47 | 3.47 | 3.47 | 3.47 | 3.47 | 3.47 | 3.47 | 3.47 |
Reserves | -1.92 | -2.16 | -2.98 | -3.06 | -3.21 | -3.33 | -3.35 | -3.40 | -3.46 | -3.52 | -3.78 | -3.62 |
0.05 | 0.05 | 0.00 | 0.00 | 0.08 | 0.08 | 0.00 | 0.04 | 0.04 | 0.04 | 1.24 | 1.48 | |
0.14 | 0.08 | 0.11 | 0.72 | 0.66 | 0.73 | 0.13 | 0.12 | 0.19 | 0.35 | 0.14 | 3.65 | |
Total Liabilities | 1.67 | 1.37 | 0.53 | 1.13 | 1.00 | 0.95 | 0.25 | 0.23 | 0.24 | 0.34 | 1.07 | 4.98 |
1.12 | 0.92 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
0.55 | 0.45 | 0.53 | 1.13 | 1.00 | 0.95 | 0.25 | 0.23 | 0.24 | 0.34 | 1.07 | 4.98 | |
Total Assets | 1.67 | 1.37 | 0.53 | 1.13 | 1.00 | 0.95 | 0.25 | 0.23 | 0.24 | 0.34 | 1.07 | 4.98 |
Cash Flows
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0.06 | 0.06 | -0.78 | -0.15 | -0.12 | -0.04 | 0.01 | -0.01 | 0.00 | 0.11 | -1.19 | -0.36 | |
0.02 | 0.00 | 0.70 | 0.02 | 0.06 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
-0.17 | 0.00 | 0.08 | 0.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.20 | 0.24 | |
Net Cash Flow | -0.09 | 0.07 | 0.00 | 0.01 | -0.06 | -0.01 | 0.01 | -0.01 | 0.00 | 0.11 | 0.01 | -0.12 |
Ratios
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 159.37 | 342.19 | 0.00 | 438.00 | 2,920.00 | 5,402.00 | 94.63 | 2,555.00 | 2,190.00 | 2,920.00 | 381.66 | |
Inventory Days | 0.00 | 0.00 | 0.00 | 20.66 | 91.25 | 0.00 | 0.00 | 0.00 | 730.00 | 235.59 | ||
Days Payable | 392.55 | 3,011.25 | 4,015.00 | 602.25 | ||||||||
Cash Conversion Cycle | 159.37 | 342.19 | 0.00 | 66.11 | 0.00 | 5,402.00 | 94.63 | 2,555.00 | -1,095.00 | 2,920.00 | 15.00 | |
Working Capital Days | 97.68 | 228.12 | 232.27 | 146.00 | 689.44 | 438.00 | -67.59 | -1,825.00 | -4,015.00 | 23,725.00 | 156.00 | |
ROCE % | -10.56% | -7.80% | -12.87% | -19.28% | -40.00% | -42.86% | -11.76% | -43.48% | -75.00% | -250.00% | -52.17% | 2.65% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
1d - Newspaper Advertisement of extract of Audited Financial Results for Quater and Year ended on 31st March, 2025
-
Integrated Filing (Financial)
2d - Audited FY25 results with modified audit opinion; accumulated losses exceed capital; financial stress noted.
- Submission Of Audited Financial Results Along With Audit Report Thereon For The Quarter And Year Ended On 31St March, 2025 2d
-
Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday, 20Th May, 2025.
2d - Hemo Organic reports FY25 audited results with losses, audit qualification, and appoints secretarial/internal auditors.
-
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Tuesday, 20Th May, 2025.
16 May - Board meeting on 20 May 2025 to approve audited financial results for FY ending 31 March 2025.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Product Profile:[1][2]
Company used to manufacture 2,6 Di Chloro Aniline which is used as an intermediate in bulk drugs and Para Chloro Meta Cresol which is used in the leather industry in its Kheda plant with an installed capacity of 110 MTPA for 2,6 Dichloro aniline and 220 MTPA for para Chloro Meta Cresol. At present, company deals in ayurvedic or unani preparations